James Engelhart Biohaven Pharmaceutical Holding CO Ltd. (BHVN) insider trading activity

James Engelhart is Strategic Advisor of Biohaven Pharmaceutical Holding Co Ltd.. Currently has a direct ownership of 0 shares of BHVN, which is worth approximately $0. The most recent transaction as insider was on Oct 03, 2022, when has been sold 15,900 shares (Common Shares) at a price of $148.5 per share, resulting in proceeds of $2,361,150. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

0% 12M change

Total Value Held $0

James Engelhart Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Oct 03 2022	SELL Sale (or disposition) back to the issuer	$2,361,150 $148.5 p/Share	15,900 Reduced 100.0%	0 Common Shares
Jan 07 2022	SELL Payment of exercise price or tax liability	$164,825 $128.87 p/Share	1,279 Reduced 7.54%	15,673 Common Shares
Jan 07 2022	BUY Exercise of conversion of derivative security	-	3,250 Added 16.09%	16,952 Common Shares
Jan 06 2022	SELL Payment of exercise price or tax liability	$189,754 $123.86 p/Share	1,532 Reduced 10.06%	13,702 Common Shares
Jan 06 2022	BUY Exercise of conversion of derivative security	-	3,750 Added 19.75%	15,234 Common Shares
Dec 10 2021	SELL Open market or private sale	$3,599,750 $102.85 p/Share	35,000 Reduced 75.76%	11,196 Common Shares
Dec 10 2021	BUY Exercise of conversion of derivative security	-	35,000 Added 43.11%	46,196 Common Shares
Nov 25 2021	SELL Payment of exercise price or tax liability	$198,168 $115.55 p/Share	1,715 Reduced 13.28%	11,196 Common Shares
Nov 25 2021	BUY Exercise of conversion of derivative security	-	3,700 Added 22.27%	12,911 Common Shares
Jan 06 2021	SELL Payment of exercise price or tax liability	$145,665 $83.38 p/Share	1,747 Reduced 15.94%	9,211 Common Shares
Jan 06 2021	BUY Exercise of conversion of derivative security	-	3,750 Added 25.5%	10,958 Common Shares
Nov 25 2020	SELL Payment of exercise price or tax liability	$151,255 $90.14 p/Share	1,678 Reduced 20.41%	6,544 Common Shares
Nov 25 2020	BUY Exercise of conversion of derivative security	-	3,700 Added 31.04%	8,222 Common Shares

James Engelhart

Strategic Advisor

New Haven, CT

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BHVN shares.

Notify only if

Value

Insider Trading

Get notified when an Biohaven Pharmaceutical Holding CO Ltd. insider buys or sells BHVN shares.

Notify only if

Operation

Value

Type

News

Receive news related to Biohaven Pharmaceutical Holding Co Ltd.

Track Activities on BHVN

Account